Cargando…

Efficient Divergent Synthesis of New Immunostimulant 4″-Modified α-Galactosylceramide Analogues

[Image: see text] A synthesis strategy for the swift generation of 4″-modified α-galactosylceramide (α-GalCer) analogues is described, establishing a chemical platform to comprehensively investigate the structure–activity relationships (SAR) of this understudied glycolipid part. The strategy relies...

Descripción completa

Detalles Bibliográficos
Autores principales: Janssens, Jonas, Decruy, Tine, Venken, Koen, Seki, Toshiyuki, Krols, Simon, Van der Eycken, Johan, Tsuji, Moriya, Elewaut, Dirk, Van Calenbergh, Serge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2017
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467197/
https://www.ncbi.nlm.nih.gov/pubmed/28626526
http://dx.doi.org/10.1021/acsmedchemlett.7b00107
_version_ 1783243222693183488
author Janssens, Jonas
Decruy, Tine
Venken, Koen
Seki, Toshiyuki
Krols, Simon
Van der Eycken, Johan
Tsuji, Moriya
Elewaut, Dirk
Van Calenbergh, Serge
author_facet Janssens, Jonas
Decruy, Tine
Venken, Koen
Seki, Toshiyuki
Krols, Simon
Van der Eycken, Johan
Tsuji, Moriya
Elewaut, Dirk
Van Calenbergh, Serge
author_sort Janssens, Jonas
collection PubMed
description [Image: see text] A synthesis strategy for the swift generation of 4″-modified α-galactosylceramide (α-GalCer) analogues is described, establishing a chemical platform to comprehensively investigate the structure–activity relationships (SAR) of this understudied glycolipid part. The strategy relies on a late-stage reductive ring-opening of a p-methoxybenzylidene (PMP) acetal to regioselectively liberate the 4″-OH position. The expediency of this methodology is demonstrated by the synthesis of a small yet diverse set of analogues, which were tested for their ability to stimulate invariant natural killer T-cells (iNKT) in vitro and in vivo. The introduction of a p-chlorobenzyl ether yielded an analogue with promising immunostimulating properties, paving the way for further SAR studies.
format Online
Article
Text
id pubmed-5467197
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-54671972018-06-08 Efficient Divergent Synthesis of New Immunostimulant 4″-Modified α-Galactosylceramide Analogues Janssens, Jonas Decruy, Tine Venken, Koen Seki, Toshiyuki Krols, Simon Van der Eycken, Johan Tsuji, Moriya Elewaut, Dirk Van Calenbergh, Serge ACS Med Chem Lett [Image: see text] A synthesis strategy for the swift generation of 4″-modified α-galactosylceramide (α-GalCer) analogues is described, establishing a chemical platform to comprehensively investigate the structure–activity relationships (SAR) of this understudied glycolipid part. The strategy relies on a late-stage reductive ring-opening of a p-methoxybenzylidene (PMP) acetal to regioselectively liberate the 4″-OH position. The expediency of this methodology is demonstrated by the synthesis of a small yet diverse set of analogues, which were tested for their ability to stimulate invariant natural killer T-cells (iNKT) in vitro and in vivo. The introduction of a p-chlorobenzyl ether yielded an analogue with promising immunostimulating properties, paving the way for further SAR studies. American Chemical Society 2017-05-05 /pmc/articles/PMC5467197/ /pubmed/28626526 http://dx.doi.org/10.1021/acsmedchemlett.7b00107 Text en This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
spellingShingle Janssens, Jonas
Decruy, Tine
Venken, Koen
Seki, Toshiyuki
Krols, Simon
Van der Eycken, Johan
Tsuji, Moriya
Elewaut, Dirk
Van Calenbergh, Serge
Efficient Divergent Synthesis of New Immunostimulant 4″-Modified α-Galactosylceramide Analogues
title Efficient Divergent Synthesis of New Immunostimulant 4″-Modified α-Galactosylceramide Analogues
title_full Efficient Divergent Synthesis of New Immunostimulant 4″-Modified α-Galactosylceramide Analogues
title_fullStr Efficient Divergent Synthesis of New Immunostimulant 4″-Modified α-Galactosylceramide Analogues
title_full_unstemmed Efficient Divergent Synthesis of New Immunostimulant 4″-Modified α-Galactosylceramide Analogues
title_short Efficient Divergent Synthesis of New Immunostimulant 4″-Modified α-Galactosylceramide Analogues
title_sort efficient divergent synthesis of new immunostimulant 4″-modified α-galactosylceramide analogues
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467197/
https://www.ncbi.nlm.nih.gov/pubmed/28626526
http://dx.doi.org/10.1021/acsmedchemlett.7b00107
work_keys_str_mv AT janssensjonas efficientdivergentsynthesisofnewimmunostimulant4modifiedagalactosylceramideanalogues
AT decruytine efficientdivergentsynthesisofnewimmunostimulant4modifiedagalactosylceramideanalogues
AT venkenkoen efficientdivergentsynthesisofnewimmunostimulant4modifiedagalactosylceramideanalogues
AT sekitoshiyuki efficientdivergentsynthesisofnewimmunostimulant4modifiedagalactosylceramideanalogues
AT krolssimon efficientdivergentsynthesisofnewimmunostimulant4modifiedagalactosylceramideanalogues
AT vandereyckenjohan efficientdivergentsynthesisofnewimmunostimulant4modifiedagalactosylceramideanalogues
AT tsujimoriya efficientdivergentsynthesisofnewimmunostimulant4modifiedagalactosylceramideanalogues
AT elewautdirk efficientdivergentsynthesisofnewimmunostimulant4modifiedagalactosylceramideanalogues
AT vancalenberghserge efficientdivergentsynthesisofnewimmunostimulant4modifiedagalactosylceramideanalogues